Skip to content
Why you as a health care investor should join us...
Whether institutional, private equity, family office, infrastructure or sovereign wealth, here is why you should attend Healthcare Business International 2023.
You know that health care services represent an incredible opportunity in just about every geography. You also know that deals are increasingly international. And yet right now valuations and the relationship between payors and providers are at a crossroads.
Healthcare Business International, now in its thirteenth year, is the only CEO-level event for the sector across Europe and Emerging Markets. In 2023 we expect over 700 delegates, including several hundred operator CEOs, from 40 countries.
As an investor, no matter where you are in the world you should join them in 2023. Here is why investors from specialist, small-cap PE houses up to institutional investors attend:
Here is what past delegates have said about the event...
HBI is the number one international healthcare event which I've always appreciated from pre-Covid times. I'm really glad that we're back and able to walk around and meet people again in person.
Wolfgang Hofmann, Head of Group Strategy and Corporate M&A, Fresenius Group
A very efficient way to meet a lot of the operators and investors across Europe and a unique chance to test the pulse and sentiment of operators in all the different jurisdictions in Europe simultaneously.
Andrea Auteri - Senior VP, European Acquisitions - HCP UK
What I like about this conference is that you have so many operators, not only investors, but operators and advisors and people who work in healthcare.
Pii Ketvel, CEO, Marcol Capital Europe
Good presentations, with insights and trends at country and sector levels. Impressive delegate attendance of investors and CEOs. Very well organised.
Zeina Bain, Director, Carlyle Group
HBI brings together the relevant stakeholders across the industry from providers to investors to advisers. That paves the way for very interesting discussions and to enable knowledge exchange between various players as well as planting the seeds for future partnerships.
Mohamad Hamade, CEO, Amanat Holdings, Investor, UAE
HBI is an absolute must for anyone who wants to get a real feel of how healthcare is developing in Europe.
Ilian Grigorov, CEO, Darzalas Capital, Bulgaria
They come for four reasons:
Meet operators and investors
This is a rare opportunity to meet a wide range of operators at CEO and CXO level as well as specialised health care service investors. In 2022 we had over 150 investor delegates and over 200 operators.
Understand the sector landscape – internationally
Nowhere else will you get such an insightful view of the sector. You will find sessions focused on sectors such as elderly care, outpatient, diagnostics, oncology, adult care and mental health as well as sessions focused on specific regions including the GCC and DACH
Insights that top up your expertise
It’s hard to keep up with developments in this high-growth, fast-moving sector. Nowhere is better than HBI 2023 for provoking new thinking. Our CEO speakers deliver real insights into everything from quality to workforce and from payor relations to how groups are really using eHealth.
Understand how investment sentiment is changing
Rothschild delivers a definitive analysis of the sector globally. This is followed by discussions from experienced investors on Europe and Emerging Markets.
Perhaps it is not surprising that many investors send teams. Book your place at HBI 2023 now.
Any questions? Call us now on 00 44 207 183 3779
Final discount saving ends in...
See who is attending
Featured Speakers
Sessions include:
Tuesday June 20, 2023
Investing in Europe
How do major investors in the sector view the challenges it faces? How do they view environmental, societal and governance issues? In which sectors and countries do they see opportunities?
Martin Henrichs, Head of Healthcare EMEA, UBS
Nikolaus Woloszczuk, Senior Managing Partner, Stonepeak
Inaki Cobo, Partner, Private Equity, KKR
Viviana Kane, Managing Director, EQT Partners
Moderated by Max Hotopf, Founder and Chairman, HBI
Fleming - 3rd Floor
Tuesday June 20, 2023
Investing in Emerging Markets
Bearing the brunt of inadequate health systems, low and middle-income countries are ripe for investment opportunities from the private sector. This session with leading emerging market investors outlines the challenges and the opportunities for investment, growth and innovation.
Amaury Guerrero, CEO, Opty / Patria Group
Zeynep Kantur, Global Manager & Global Head of Health, IFC
Dr Stephen Sammut, Chair, Industry Advisory Board, Alta Semper Capital
Jide Olanrewaju, Managing Director, TPG Rise
Moderated by Max Ateba, Associate Partner, Dalberg Advisors
Fleming - 3rd Floor
Tuesday June 20, 2023
Investing in Health Care Property
A conversation with some of the largest health care property investors discussing topics such as: How robust is health care real estate to rising inflation? What ESG frameworks are in place and what is lacking? What impact is the lack of available debt having on transactions?
Speakers include:
Stephane Pichon, Founder and Managing Partner, Your Care Consult
Steven Hamner, CFO & Co-Founder, MPT
Xavier Cheval, CEO, Icade
Moderated by Hugh Risebrow, Managing Director, Latchmore Associates
St James - 4th Floor
Tuesday June 20, 2023
Investing in MENA
Opportunities in the MENA, in particular in Saudi Arabia, are gigantic but accessing and understanding these markets isn’t easy, it requires strong local knowledge and partners to be successful. In a highly competitive, brand-oriented market getting it wrong is disastrous. This session discusses the opportunities and gives practical advice on how to succeed.
The session is followed by a networking break to provide delegates with an opportunity to meet local partners and investors from the region.
Panelists include Youssef Haidar, Founder and CEO, StonePine Capital Partners, who has invested extensively across the GCC and the wider Middle East. Nexus Gulf, a company co-founded by StonePine and led by Youssef, has partnerships with European groups including Alliance Medical and Cerba
Dr Adil Monshi, Director General for Investment Promotions, Ministry of Health, Saudi Arabia
Michael Ferstl, General Manager, Vamed
Abhishek Sharma, Founder CEO, Foundation Holdings
Moderated by Hamid Yunis, Partner, McDermott, Will & Emery
St James - 4th Floor
Tuesday June 20, 2023
Investing in DACH
The 100m population of wealthy German-speaking countries is by far the largest market for healthcare services in Europe. What will be the trajectory for future consolidation, who are the players and what is the opportunity? A wide-ranging exploration with expert advisors, investors and operators discussing the region’s investment opportunities, growth sectors and regulatory environment.
Speakers include:
Andreas Ludowig, CEO, Kinios
Dirk Knueppel, CEO, Primärmedizin TMVZ GmbH
Julius Hugelshofer, Senior Principal, Verlinvest
Philipp von Hammerstein, Partner, Health& Care, Gimv
Moderated by Dr Stephan Rau, Partner, McDermott, Will & Emery
Backed by Triton Partners, Kinios is consolidating the German outpatient orthopaedic space. Leveraging the scale of Kielstein group, Germany’s largest primary care network, Primarmedizin is looking to build an outpatient network specialising in internal medicine.
Whittle - 3rd Floor
Tuesday June 20, 2023
Investing in UK and Ireland
The UK remains by far the largest market for private equity investment in Europe. But what are the dynamics post-Covid and post-Brexit? A wide-ranging exploration with expert advisors, investors and operators discussing the region’s investment opportunities, growth sectors and regulatory environment.
Speakers include:
Katie Beckingham, Director, August Equity LLP
Alan Hughes, Founder, LIT Healthcare
James Tugendhat, CEO, HC-One
Dr Charles Niehaus, Executive Director, Affidea Group
Moderated by Sharon Lamb, Partner, McDermott, Will & Emery
Whittle - 3rd Floor
Wednesday June 21, 2023
Opportunities in Nursing Homes
Growth projections have always been difficult in the elderly care sector – and now even challenged as a result of Covid- 19 and scandals which rocked the sector in 2022. Our panel of experts share their views on the opportunities and challenges as we look ahead to the next 3 years.
Speakers include:
Buyanzaya Batbileg, Head of Investment, Threestones Capital Investment
Threestones has three funds totalling more than a billion Euros investing in nursing homes in Germany, Italy and Spain
Nate McLemore, Managing Director, Columbia Pacific Management
Dr Sanjeev Kanoria, Founder and Chairman, Advinia Health Care
Moderated by Michaila Byrne, Senior Analyst, HBI
Westminster - 4th Floor
Wednesday June 21, 2023
The investment opportunity in fertility and women’s health
The fertility sector continues to steadily grow, but with a fragmented market, consolidation is not straightforward. And the revolution to address health inequalities for women presents a huge opportunity – around fertility, pregnancy and the menopause. Meanwhile femtech is set to be a $50bn industry by 2025. This session looks in depth at future growth prospects with speakers from two of the largest international consolidators – Virtus and TFP.
Speakers include:
Richard Banks, Group Chief Strategy Officer & European Managing Director, Virtus Health
Australian-based fertility group, Virtus was the subject of a bidding war in 2022 highlighting the growth opportunity in fertility services. With 25 clinics in the UK, Denmark, Netherlands, Poland, Austria and Germany the Impilo owned group is focussed on dominating the northern European market.
Johannes Roehren, Group CEO, TFP Fertility
Katya Zubareva, Partner, L.E.K. Consulting
Annie Coleridge, Product Director, Corporate, SimplyHealth
Moderated by Hugh Risebrow, Managing Director, Latchmore Associates
Whittle - 3rd Floor
Wednesday June 21, 2023
Opportunities in Mental Health
The world faces a mental health pandemic. How far can this be met by digital therapeutics and how can operators consolidate this fragmented sector? And how far are more acute psychiatric needs being addressed in the for-profit sector? Participants include Andre Schmidt, Group CEO Median, the biggest German rehabilitation group which acquired the Priory, the UK’s largest mental health provider in late 2020 and Petri Bono, CMO at Terveystalo, which has reduced mental health absences at client companies by 40%.
Speakers include:
Petri Bono, Chief Medical Officer, Terveystalo
Petri shares how Finlands largest private health and occupational health group developed new, cost efficient patient pathways that lead to a 40% decrease in mental health absences.
Dr Andre Schmidt, Group CEO, MEDIAN
Alexandra Prieux, CEO, ALCEDIAG
Simon Miller, International Partnerships Lead, Headspace Health
Moderated by Dr Stefan Schrettle, Partner, L.E.K. Consulting
St James - 4th Floor
Wednesday June 21, 2023
The evolution in Primary Care
The huge primary care sector in Europe holds the key to outpatient consolidation. Here we look at how operators are pairing it with digital and telehealth, pharmacies and imaging, and at how they are reimagining its delivery and business models.
Speakers include:
Dr Murray Ellender, CEO and Co-Founder, eConsult Health
Lyndsey Reeves, Director of Operations UK, Kry/Livi
Dirk Knueppel, CEO, Primärmedizin TMVZ GmbH
Martin Lindman, CEO, Doktor.Se
Moderated by Martin Debenito-Gellner, Senior Analyst, HBI
Whittle - 3rd Floor
Wednesday June 21, 2023
Opportunities in Oncology
There is still a long way to go to build capacity in oncology care, but with huge investor interest, linked to the close synergies with imaging diagnostics, the opportunities are huge. Add in public sector outsourcing and there’s a lot of room for growth. This session explores the opportunities and analyses the best models to build capacity. Ralf Kurek heads up one of the largest players in the sector internationally.
Speakers include:
Dr Ralf Kurek, Executive Partner, RadioOnkologieNetzwerk, Ergéa Group
Ralph Hefti, CEO, Stingray Healthcare
Nikos Paragios, CEO, TheraPanacea
Moderated by Joe Quiruga, Analyst, HBI
Radiotherapy and outpatient oncology is another key sector for consolidation across Europe with investors such as DWS, owners of RON through Medipass, and Infravia building Pan-European chains. Here Ralf takes the lid off RON’s business model
Fleming - 3rd Floor
